🇪🇺 Aryplase in European Union

EMA authorised Aryplase on 24 January 2006

Marketing authorisation

EMA — authorised 24 January 2006

  • Status: approved

Aryplase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Aryplase approved in European Union?

Yes. EMA authorised it on 24 January 2006.

Who is the marketing authorisation holder for Aryplase in European Union?

BioMarin is the originator. The local marketing authorisation holder may differ — check the official source linked above.